ABEXPRUV Trademark

Trademark Overview

On Thursday, February 10, 2022, a trademark application was filed for ABEXPRUV with the United States Patent and Trademark Office. The USPTO has given the ABEXPRUV trademark a serial number of 97261429. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, October 25, 2024. This trademark is owned by Principia Biopharma Inc.. The ABEXPRUV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of multiple sclerosis
abexpruv

General Information

Serial Number97261429
Word MarkABEXPRUV
Filing DateThursday, February 10, 2022
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, October 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of multiple sclerosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePrincipia Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807
Party NamePrincipia Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Monday, February 14, 2022NEW APPLICATION ENTERED
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 4, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, March 7, 2022ASSIGNED TO LIE
Tuesday, March 8, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, March 11, 2022ASSIGNED TO EXAMINER
Friday, March 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 3, 2022SOU TEAS EXTENSION RECEIVED
Thursday, November 3, 2022SOU EXTENSION 1 FILED
Thursday, November 3, 2022SOU EXTENSION 1 GRANTED
Saturday, November 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 24, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 24, 2023SOU EXTENSION 2 FILED
Monday, April 24, 2023SOU EXTENSION 2 GRANTED
Wednesday, April 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 6, 2023SOU EXTENSION 3 FILED
Monday, November 6, 2023SOU EXTENSION 3 GRANTED
Wednesday, November 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 24, 2024SOU EXTENSION 4 FILED
Wednesday, April 24, 2024SOU EXTENSION 4 GRANTED
Thursday, April 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2024SOU EXTENSION 5 FILED
Friday, October 25, 2024SOU EXTENSION 5 GRANTED

Related Keywords

abexpruv sclerosis multiple treatment preparations pharmaceutical